215 related articles for article (PubMed ID: 23909855)
21. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
Suman VJ; Dueck A; Sargent DJ
Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764
[No Abstract] [Full Text] [Related]
22. Early phase clinical trials in pediatric hematology and oncology.
Corbacioglu S
Klin Padiatr; 2012 Apr; 224(3):197-200. PubMed ID: 22511313
[TBL] [Abstract][Full Text] [Related]
23. Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma.
Löscher W; Schmidt D
Epilepsia; 2011 Apr; 52(4):657-78. PubMed ID: 21426333
[TBL] [Abstract][Full Text] [Related]
24. Loreclezole.
De Beukelaar F; Tritsmans L
Epilepsy Res Suppl; 1991; 3():125-8. PubMed ID: 1777067
[No Abstract] [Full Text] [Related]
25. Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI).
Bialer M; Johannessen SI; Levy RH; Perucca E; Tomson T; White HS
Epilepsy Res; 2013 Jan; 103(1):2-30. PubMed ID: 23219031
[TBL] [Abstract][Full Text] [Related]
26. Stiripentol.
Vincent JC
Epilepsy Res Suppl; 1991; 3():153-6. PubMed ID: 1777073
[No Abstract] [Full Text] [Related]
27. Joint AES/ILAE translational workshop to optimize preclinical epilepsy research.
Galanopoulou AS; Simonato M; French JA; O'Brien TJ
Epilepsia; 2013 Aug; 54 Suppl 4():1-2. PubMed ID: 23909848
[No Abstract] [Full Text] [Related]
28. Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients.
Chadwick D; Marson T
Epilepsia; 2007 Jul; 48(7):1259-63. PubMed ID: 17442006
[TBL] [Abstract][Full Text] [Related]
29. Investigational small molecules in phase II clinical trials for the treatment of epilepsy.
Greco M; Varriale G; Coppola G; Operto F; Verrotti A; Iezzi ML
Expert Opin Investig Drugs; 2018 Dec; 27(12):971-979. PubMed ID: 30408428
[TBL] [Abstract][Full Text] [Related]
30. Alternative strategies in drug development: clinical pharmacological aspects.
Kuhlmann J
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
[TBL] [Abstract][Full Text] [Related]
31. Monotherapy clinical trial design.
Sachdeo R
Neurology; 2007 Dec; 69(24 Suppl 3):S23-7. PubMed ID: 18071154
[TBL] [Abstract][Full Text] [Related]
32. Zonisamide.
Seino M; Miyazaki H; Ito T
Epilepsy Res Suppl; 1991; 3():169-74. PubMed ID: 1777076
[No Abstract] [Full Text] [Related]
33. Ralitoline.
Anhut H; Satzinger G; von Hodenberg A
Epilepsy Res Suppl; 1991; 3():141-5. PubMed ID: 1777070
[No Abstract] [Full Text] [Related]
34. Lamotrigine.
Yuen AW
Epilepsy Res Suppl; 1991; 3():115-23. PubMed ID: 1777066
[No Abstract] [Full Text] [Related]
35. Lamotrigine in refractory epilepsy: a long-term open study.
Pisani F; Russo M; Trio R; Artesi C; Fazio A; Oteri G; Di Perri R
Epilepsy Res Suppl; 1991; 3():187-91. PubMed ID: 1777079
[No Abstract] [Full Text] [Related]
36. Oxcarbazepine.
Jensen PK; Gram L; Schmutz M
Epilepsy Res Suppl; 1991; 3():135-40. PubMed ID: 1777069
[No Abstract] [Full Text] [Related]
37. Losigamone.
Stein U; Klessing K; Chatterjee SS
Epilepsy Res Suppl; 1991; 3():129-33. PubMed ID: 1777068
[No Abstract] [Full Text] [Related]
38. Innovative clinical trial designs for future antiepileptic drugs.
Dichter MA
Epilepsia; 2007; 48 Suppl 1():26-30. PubMed ID: 17316410
[TBL] [Abstract][Full Text] [Related]
39. Disease modification in epilepsy: from animal models to clinical applications.
Barker-Haliski ML; Friedman D; French JA; White HS
Drugs; 2015 May; 75(7):749-67. PubMed ID: 25925798
[TBL] [Abstract][Full Text] [Related]
40. Antiepileptic drug therapy in the United States: a review of clinical studies and unmet needs.
Pellock JM
Neurology; 1995 Mar; 45(3 Suppl 2):S17-24. PubMed ID: 7898741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
